Literature DB >> 20638943

Withdrawal from chronic amphetamine produces persistent anxiety-like behavior but temporally-limited reductions in monoamines and neurogenesis in the adult rat dentate gyrus.

Jeffrey L Barr1, Kenneth J Renner, Gina L Forster.   

Abstract

Acute amphetamine administration activates monoaminergic pathways and increases systemic corticosterone, both of which influence anxiety states and adult dentate gyrus neurogenesis. Chronic amphetamine increases anxiety states in rats when measured at 24 h and at 2 weeks of withdrawal. However, the effects of chronic amphetamine exposure and withdrawal on long term anxiety-like behavior and adult neurogenesis in the dentate gyrus are unknown. Adult male rats were administered amphetamine (2.5 mg/kg, ip.) daily for two weeks. Anxiety-like behaviors were increased markedly in amphetamine-treated rats following four weeks of withdrawal from amphetamine. Plasma corticosterone level was unaltered by amphetamine treatment or withdrawal. However, norepinephrine and serotonin concentrations were selectively reduced in the dentate gyrus 20 h following amphetamine treatment. This effect did not persist through the four week withdrawal period. In separate experiments, rats received bromodeoxyuridine to label cells in S-phase, prior to or immediately following amphetamine treatment. Newly generated cells were quantified to measure extent of progenitor cell proliferation and neurogenesis following treatment or withdrawal. Progenitor cell proliferation and neurogenesis were not significantly affected by amphetamine exposure when measured 20 h following the last amphetamine treatment. However, neurogenesis in the dentate gyrus was reduced after four weeks of withdrawal when compared to saline-pretreated rats. Overall, our findings indicate that withdrawal from chronic amphetamine leads to persistent anxiety-like behavior which may be maintained by reduced neurogenesis in the dentate gyrus at this protracted withdrawal time point. However, neurogenesis is unaffected at earlier withdrawal time points where anxiety states emerge, suggesting different mechanisms may underlie the emergence of anxiety states during amphetamine withdrawal.
Copyright © 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20638943      PMCID: PMC2946460          DOI: 10.1016/j.neuropharm.2010.05.011

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  101 in total

1.  Behavioural and neurochemical responses evoked by repeated exposure to an elevated open platform.

Authors:  J D Storey; D A F Robertson; J E Beattie; I C Reid; S N Mitchell; D J K Balfour
Journal:  Behav Brain Res       Date:  2005-09-15       Impact factor: 3.332

Review 2.  Opiates, psychostimulants, and adult hippocampal neurogenesis: Insights for addiction and stem cell biology.

Authors:  Amelia J Eisch; Gwyndolen C Harburg
Journal:  Hippocampus       Date:  2006       Impact factor: 3.899

3.  Stimulation of neurogenesis in the hippocampus of the adult rat by fluoxetine requires rhythmic change in corticosterone.

Authors:  Guo-Jen Huang; Joe Herbert
Journal:  Biol Psychiatry       Date:  2005-12-02       Impact factor: 13.382

4.  Amphetamine increases tyrosine kinase-B receptor expression in the dorsal striatum.

Authors:  Gloria E Meredith; Heinz Steiner
Journal:  Neuroreport       Date:  2006-01-23       Impact factor: 1.837

5.  Inhibition of neurogenesis interferes with hippocampus-dependent memory function.

Authors:  Gordon Winocur; J Martin Wojtowicz; Melanie Sekeres; Jason S Snyder; Sabrina Wang
Journal:  Hippocampus       Date:  2006       Impact factor: 3.899

6.  GABA regulates synaptic integration of newly generated neurons in the adult brain.

Authors:  Shaoyu Ge; Eyleen L K Goh; Kurt A Sailor; Yasuji Kitabatake; Guo-li Ming; Hongjun Song
Journal:  Nature       Date:  2005-12-11       Impact factor: 49.962

7.  The alpha2-adrenoceptor antagonist dexefaroxan enhances hippocampal neurogenesis by increasing the survival and differentiation of new granule cells.

Authors:  Pamela Rizk; Julio Salazar; Rita Raisman-Vozari; Marc Marien; Merle Ruberg; Francis Colpaert; Thomas Debeir
Journal:  Neuropsychopharmacology       Date:  2006-06       Impact factor: 7.853

8.  Differential effects of 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy") on BDNF mRNA expression in rat frontal cortex and hippocampus.

Authors:  Rebeca Martínez-Turrillas; Sonia Moyano; Joaquín Del Río; Diana Frechilla
Journal:  Neurosci Lett       Date:  2006-04-27       Impact factor: 3.046

9.  Increased generation of granule cells in adult Bcl-2-overexpressing mice: a role for cell death during continued hippocampal neurogenesis.

Authors:  H Georg Kuhn; Manfred Biebl; Daniel Wilhelm; Mingwei Li; Robert M Friedlander; Jürgen Winkler
Journal:  Eur J Neurosci       Date:  2005-10       Impact factor: 3.386

10.  Raised circulating corticosterone inhibits neuronal differentiation of progenitor cells in the adult hippocampus.

Authors:  E Y H Wong; J Herbert
Journal:  Neuroscience       Date:  2005-11-10       Impact factor: 3.590

View more
  25 in total

1.  Protracted manifestations of acute dependence after a single morphine exposure.

Authors:  Patrick E Rothwell; Mark J Thomas; Jonathan C Gewirtz
Journal:  Psychopharmacology (Berl)       Date:  2011-08-11       Impact factor: 4.530

2.  A stress steroid triggers anxiety via increased expression of α4βδ GABAA receptors in methamphetamine dependence.

Authors:  H Shen; A Mohammad; J Ramroop; S S Smith
Journal:  Neuroscience       Date:  2013-08-29       Impact factor: 3.590

Review 3.  Effects of addictive drugs on adult neural stem/progenitor cells.

Authors:  Chi Xu; Horace H Loh; Ping-Yee Law
Journal:  Cell Mol Life Sci       Date:  2015-10-14       Impact factor: 9.261

4.  Timing of amphetamine exposure in relation to puberty onset determines its effects on anhedonia, exploratory behavior, and dopamine D1 receptor expression in young adulthood.

Authors:  Shuo Kang; Mariah M Wu; Roberto Galvez; Joshua M Gulley
Journal:  Neuroscience       Date:  2016-10-01       Impact factor: 3.590

Review 5.  Adult hippocampal neurogenesis in the pathogenesis of addiction and dual diagnosis disorders.

Authors:  R Andrew Chambers
Journal:  Drug Alcohol Depend       Date:  2012-12-29       Impact factor: 4.492

6.  Serotonergic responses to stress are enhanced in the central amygdala and inhibited in the ventral hippocampus during amphetamine withdrawal.

Authors:  Hao Li; Jamie L Scholl; Wenyu Tu; James E Hassell; Michael J Watt; Gina L Forster; Kenneth J Renner
Journal:  Eur J Neurosci       Date:  2014-09-19       Impact factor: 3.386

7.  Serotonergic neurotransmission in the ventral hippocampus is enhanced by corticosterone and altered by chronic amphetamine treatment.

Authors:  J L Barr; G L Forster
Journal:  Neuroscience       Date:  2011-03-21       Impact factor: 3.590

8.  Influence of chronic amphetamine treatment and acute withdrawal on serotonin synthesis and clearance mechanisms in the rat ventral hippocampus.

Authors:  Jeffrey L Barr; Jamie L Scholl; Rajeshwari R Solanki; Michael J Watt; Christopher A Lowry; Kenneth J Renner; Gina L Forster
Journal:  Eur J Neurosci       Date:  2012-11-14       Impact factor: 3.386

9.  Abstinence from repeated amphetamine treatment induces depressive-like behaviors and oxidative damage in rat brain.

Authors:  Yi Che; Yong-Hua Cui; Hua Tan; Ana C Andreazza; L Trevor Young; Jun-Feng Wang
Journal:  Psychopharmacology (Berl)       Date:  2013-02-01       Impact factor: 4.530

10.  Amphetamine withdrawal differentially affects hippocampal and peripheral corticosterone levels in response to stress.

Authors:  Brenna Bray; Jamie L Scholl; Wenyu Tu; Michael J Watt; Kenneth J Renner; Gina L Forster
Journal:  Brain Res       Date:  2016-05-18       Impact factor: 3.252

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.